Sustained lung inflation at birth: what do we know, and what do we need to know?

被引:13
|
作者
McCall, Karen E. [1 ,2 ]
Davis, Peter G. [1 ,3 ,4 ]
Owen, Louise S. [1 ,3 ,4 ]
Tingay, David G. [1 ,4 ,5 ,6 ]
机构
[1] Murdoch Childrens Res Inst, Newborn Res, Melbourne, Vic, Australia
[2] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland
[3] Univ Melbourne, Dept Obstet, Melbourne, Vic, Australia
[4] Royal Womens Hosp, Neonatal Res, Melbourne, Vic, Australia
[5] Royal Childrens Hosp, Dept Neonatol, Melbourne, Vic, Australia
[6] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
FUNCTIONAL RESIDUAL CAPACITY; RESPIRATORY-DISTRESS-SYNDROME; MANUAL VENTILATION DEVICES; T-PIECE RESUSCITATOR; NEONATAL RESUSCITATION; PRETERM INFANTS; MASK VENTILATION; CARDIOPULMONARY-RESUSCITATION; VOLUME VENTILATION; WEIGHT INFANTS;
D O I
10.1136/archdischild-2015-309611
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A sustained inflation has been advocated as a potential method of augmenting lung aeration at birth. Clinical trials have suggested that a sustained inflation may lead to a reduced need for intubation and ventilation in the first few days of life, without cardiovascular compromise or increased lung injury. Despite this, a sustained inflation is not currently a standard of practice, mainly due to a lack of clarity regarding the optimal delivery method. Animal trials have sought to refine delivery techniques. This review will outline current recommendations regarding a sustained inflation, discuss potential strategies for its optimal delivery and suggest priorities for future research.
引用
收藏
页码:F175 / F180
页数:6
相关论文
共 50 条
  • [1] What do we know? What do we need to know?
    Milena J. Henzlova
    W. Lane Duvall
    [J]. Journal of Nuclear Cardiology, 2017, 24 : 252 - 254
  • [2] What do we know? What do we need to know?
    Henzlova, Milena J.
    Duvall, W. Lane
    [J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (01) : 252 - 254
  • [3] Erratum to: What do we know? What do we need to know?
    Milena J. Henzlova
    W. Lane Duvall
    [J]. Journal of Nuclear Cardiology, 2017, 24 (1) : 255 - 255
  • [4] Lung cancer and inhaled carcinogens: What do we know and what do we need to know?
    Samet, Jonathan M.
    [J]. TOXICOLOGIC PATHOLOGY, 2006, 34 (07) : 981 - 981
  • [5] What do we know, what do we need to know and how do we apply it?
    Lawrence, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S37 - S37
  • [6] Diversity: What We Know, What We Need to Know, and What We Need to Do
    Dukes, Charles
    Lamar-Dukes, Pamela
    [J]. RESEARCH AND PRACTICE FOR PERSONS WITH SEVERE DISABILITIES, 2009, 34 (3-4) : 71 - 75
  • [7] Zebrafish and steroids: What do we know and what do we need to know?
    Tokarz, Janina
    Moeller, Gabriele
    de Angelis, Martin Hrabe
    Adamski, Jerzy
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 137 : 165 - 173
  • [8] Managing dyspepsia: What do we know and what do we need to know?
    Rabeneck, L
    Wray, NP
    Graham, DY
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (06): : 920 - 924
  • [9] Fear of falling: What do we know, what do we need to know?
    Lach, HW
    [J]. GERONTOLOGIST, 2001, 41 : 387 - 387
  • [10] ECONOMIC NETWORKS: WHAT DO WE KNOW AND WHAT DO WE NEED TO KNOW?
    Schweitzer, Frank
    Fagiolo, Giorgio
    Sornette, Didier
    Vega-Redondo, Fernando
    White, Douglas R.
    [J]. ADVANCES IN COMPLEX SYSTEMS, 2009, 12 (4-5): : 407 - 422